Breast reconstruction

Braving New Frontiers in Cancer Monitoring - Learn Look Locate (LLL) Hosts Educational Natera™ Site for Personalized Signatera™ Tests

Retrieved on: 
Monday, December 11, 2023
Empowerment, Woman, DNA, LLL, Medical director, Neoplasm, Breast cancer, Patient, Natera, MRD, Genetic testing, Cancer, Diagnosis, Breast reconstruction, Aftercare, Recurrence, Knowledge, Education, Vaccine, Medical imaging, Mammography

TUCSON, Ariz., Dec. 11, 2023 /PRNewswire/ -- Following a previous collaboration with Natera, a global cell-free DNA testing leader, LLL announced that it would host a dedicated webpage,  for Natera's revolutionary molecular residual disease assay (MRD) test: Signatera. MRD is used to describe the small amount of residual cancer cells that patients retain after cancer treatment and is used as a major predictor of relapse. The new LLL page will highlight the benefits of Signatera, while also giving patients and readers access to LLL's vast archive of breast cancer resources.

Key Points: 
  • The Signatera MRD assay can detect cancer recurrence far earlier than conventional methods by monitoring circulating tumor DNA (ctDNA).
  • "Signatera takes cancer management to a whole new level," said Dr. Barry Rosen, Senior Medical Advisor for LLL.
  • Dedicated to fostering inclusive education on breast health and cancer, Learn Look Locate passionately delivers the latest advancements, ensuring every individual is empowered with knowledge.
  • Cynthia's journey fuels our mission, ensuring no one feels as scared and uneducated as she did during her breast cancer diagnosis.

RTI Surgical Inc. Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast Reconstruction

Retrieved on: 
Monday, November 27, 2023
ADM, RTI Surgical, Safety, RTI, Food, Surgeon, Breast cancer, Patient, Regenerative medicine, FDA, IDE, Trial of the century, Breast reconstruction, Investigational device exemption, PMA, Health, Dermis, Medical imaging

ALACHUA, Fla., Nov. 27, 2023 /PRNewswire/ -- RTI Surgical, a leading global medical device organization, announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for a clinical study designed to confirm the safety and effectiveness of Cortiva® Allograft Dermis in implant-based breast reconstruction.

Key Points: 
  • ALACHUA, Fla., Nov. 27, 2023 /PRNewswire/ -- RTI Surgical, a leading global medical device organization, announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for a clinical study designed to confirm the safety and effectiveness of Cortiva® Allograft Dermis in implant-based breast reconstruction.
  • Olivier Visa, President and Chief Executive Officer of RTI Surgical, emphasized the company's commitment to advancing patient care by providing human acellular dermal matrix (ADM) for individuals undergoing breast reconstruction as part of their breast cancer treatment.
  • "This milestone marks a significant step towards obtaining FDA pre-market approval (PMA) for our Cortiva® allograft implants.
  • In consultation with the FDA, RTI Surgical developed a comprehensive clinical study to support its PMA application to obtain an indication for use in breast reconstruction.

Body Expert AMG Plastic Surgery Joins Exclusive Haute Beauty Network

Retrieved on: 
Thursday, November 9, 2023
Child, Pittsburgh Steelers, Beauty, Torso, Breast reconstruction, Cooking, Case Western Reserve University, Family, Face, Maimonides Medical Center, Plastic, Health, Research, Master, Business administration, Abstract, Cleveland Clinic, Breast cancer, Sensation, Tennis, General surgery, Safety, Education, Master of Business Administration, AMG, Breast, Patient, Master's degree, Dentistry, Nursing, DMV, Microsurgery, Empathy

NEW YORK, Nov. 9, 2023 /PRNewswire-PRWeb/ -- Dr. Amir Mahan Ghaznavi is a dual-board certified plastic surgeon and a leader in the field of plastic surgery. He completed his general surgery training at Maimonides Medical Center in Brooklyn, NY. Upon completion, Dr. Ghaznavi continued his plastic surgery training at the distinguished Henry Ford Hospital System. Dr. Ghaznavi concluded his training in Microsurgery at the renowned Cleveland Clinic Foundation under the guidance of leading experts in his specialty.

Key Points: 
  • AMG Plastic Surgery joins Haute Beauty Network as a body expert representing the DMV market.
  • NEW YORK, Nov. 9, 2023 /PRNewswire-PRWeb/ -- Dr. Amir Mahan Ghaznavi is a dual-board certified plastic surgeon and a leader in the field of plastic surgery.
  • Upon completion, Dr. Ghaznavi continued his plastic surgery training at the distinguished Henry Ford Hospital System.
  • AMG Plastic Surgery sees clients for all their cosmetic and reconstructive needs of the face, breast, and body.

The 12th Annual Breast Reconstruction Awareness Day returns Oct. 18, 2023 to Increase Recognition of Options with Education, Events and Fundraisers

Retrieved on: 
Thursday, October 19, 2023
ASPS, Patient, PSF, Breast reconstruction, Synchrony Financial, Integra LifeSciences, Breast, National Fund for the Development of Arts and Crafts, Family, Plastic surgery, Skin, Health, Research, Society, Integra, Quality of life, Caregiver, BRA, Plastic, Breast cancer, American Society of Plastic Surgeons, AbbVie, Mastectomy, Movement, Medical imaging, Birth control, Nursing, Diamond, MD

ARLINGTON HEIGHTS, Ill., Oct. 19, 2023 /PRNewswire-PRWeb/ -- The American Society of Plastic Surgeons (ASPS) in collaboration with The Plastic Surgery Foundation is pleased to announce the 12th annual Breast Reconstruction Awareness Day known as BRA Day on Oct. 18, 2023.

Key Points: 
  • ARLINGTON HEIGHTS, Ill., Oct. 19, 2023 /PRNewswire-PRWeb/ -- The American Society of Plastic Surgeons (ASPS) in collaboration with The Plastic Surgery Foundation is pleased to announce the 12th annual Breast Reconstruction Awareness Day known as BRA Day on Oct. 18, 2023.
  • Many patients who undergo a mastectomy or lumpectomy because of breast cancer or other health-related conditions are not always aware of all the reconstruction options available to them.
  • Understanding their options for breast reconstruction is critical to making informed decisions about their care and fully healing.
  • ASPS and The PSF launched the Breast Reconstruction Awareness Campaign and the annual BRA Day in 2011.

Enhancing Patient Outcomes: Surge in Breast Reconstruction Drives Growth of Global Reconstruction Meshes Market to 2033 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 6, 2023
Biotechnology, Health, Surgery, Tissue, ASP, Patient satisfaction, Internet, COVID-19, Market access, Country, CMO, Strategic planning, Implant, SWOT, Mastectomy, Investment, Reading, SWOT analysis, Breast, Growth, Region, Epidemiology, LIBOR market model, Pelvic organ prolapse, General surgery, Forecast, Safety, Breast reconstruction, Urinary incontinence, Retail, Medical imaging, Health care, Risk management

The model discusses in detail the impact of COVID-19 on Reconstruction Meshes market for the year 2020 and beyond.

Key Points: 
  • The model discusses in detail the impact of COVID-19 on Reconstruction Meshes market for the year 2020 and beyond.
  • The breast reconstruction market is increasing dramatically due to improvements in patient satisfaction, reduced costs, and decreases in side-effects from procedures.
  • Use of repair meshes along with breast implants is emerging as an effective method for breast reconstruction after mastectomy.
  • Global, Regional and Country level market specific insights:
    Qualitative market specific information is available with global trends further broken down into regional trends.

Integra LifeSciences Announces Complete Enrollment in DuraSorb® Monofilament Mesh U.S. IDE Study

Retrieved on: 
Wednesday, June 28, 2023
Surgeon, PRS, Integra, Weakness, Woman, Trial of the century, Breast reconstruction, Police, PMA, SIA, Patient, IDE, Health, FDA, Safety, Breast cancer, Medical device, Medical imaging, Nursing, Sulfoxide, Brigham

PRINCETON, N.J., June 28, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, announced the completion of patient enrollment in the DuraSorb U.S. investigational device exemption (IDE) clinical study for two-stage breast reconstruction.

Key Points: 
  • PRINCETON, N.J., June 28, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq:IART), a leading global medical technology company, announced the completion of patient enrollment in the DuraSorb U.S. investigational device exemption (IDE) clinical study for two-stage breast reconstruction.
  • DuraSorb® Monofilament Mesh is a bioabsorbable matrix currently 510(K) cleared for the reinforcement of soft tissue where weakness exists.
  • The DuraSorb IDE study, which is the first and only active, prospective, multi-center IDE study in the U.S. evaluating the use of a surgical matrix in two-stage breast reconstruction, has enrolled several hundred patients from seven major academic hospitals across the country sooner than anticipated.
  • In addition to the ongoing DuraSorb U.S. IDE study, Integra was the first manufacturer to submit a PMA application with SurgiMend® PRS , a surgical matrix for use as soft tissue support in IBBR.

Tucson Plastic Surgery Celebrates Five Years as NewBeauty Top Doctors

Retrieved on: 
Friday, June 16, 2023
Partnership, Trust, Health, Beauty, Work, Patient, Safety, Patient safety, Breast reconstruction, Medical device

TUCSON, Ariz., June 16, 2023 /PRNewswire/ -- NewBeauty is pleased to recognize board-certified plastic surgeons Dr. Raman Mahabir and Dr. Silvia Kurtovic, esteemed plastic surgeons at Tucson Plastic Surgery, as they celebrate five years as NewBeauty Top Doctors. As board-certified plastic and reconstructive surgeons with a combined experience of over 22 years, Dr. Mahabir and Dr. Kurtovic have demonstrated unparalleled expertise and dedication in their craft. Specializing in various cosmetic and reconstructive procedures, they have consistently delivered transformative results that have enhanced the lives of countless patients.

Key Points: 
  • TUCSON, Ariz., June 16, 2023 /PRNewswire/ -- NewBeauty is pleased to recognize board-certified plastic surgeons Dr. Raman Mahabir and Dr. Silvia Kurtovic, esteemed plastic surgeons at Tucson Plastic Surgery, as they celebrate five years as NewBeauty Top Doctors.
  • As board-certified plastic and reconstructive surgeons with a combined experience of over 22 years, Dr. Mahabir and Dr. Kurtovic have demonstrated unparalleled expertise and dedication in their craft.
  • Renowned for their meticulous approach, personalized care, and artistic vision, Dr. Kurtovic and Dr. Mahabir have earned a sterling reputation within the Tucson community and beyond.
  • Dr. Kurtovic specializes in cosmetic breast and body surgery as well as breast reconstruction, while Dr. Mahabir specializes in facial rejuvenation, cosmetic breast and body surgery, and breast reconstruction.

Global Breast Implants Market Outlook & Forecast Report 2023: A $3.793 Billion Market by 2028 Featuring Key Vendors - AbbVie and Johnson & Johnson - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 1, 2023
Surgery, Health, Skin, Breast cancer, Social media, Johnson & Johnson, Breast augmentation, Cancer, Mastectomy, Immune system, Disorder, ASPS, Hospital, Breast reconstruction, Risk, Beauty, Investment, Patient, Medical tourism, Breast implant, Generation Z, Growth, Ageing, Surgeon, Ear drop, AbbVie, Breast, Scar, Woman, Breast enlargement, USD, Prevalence, Rupture, Birth control, Allergan

The "Breast Implants Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Breast Implants Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Global breast implants market is forecast to reach a value of $3,793.71 million by 2028 from $2,529.33 million in 2022, growing at a CAGR of 6.9%.
  • The rising mastectomy procedures and the increasing prevalence of breast cancer are driving the growth of the breast implants market.
  • Large-scale investments and funding in the global breast implants market through varied conglomerates and investment firms allow product development.

Advanced Reconstructive Surgery Alliance (ARSA) Announces New Partnership with Plastic, Reconstructive, and Microsurgical Associates (PRMA)

Retrieved on: 
Wednesday, January 11, 2023
LTP, Learning, PAP, Surgeon, GAP, SIEA, Partnership, ARSA, Growth, Plastic surgery, Plastic, Ministry of Education (Malaysia), Breast reconstruction, Breast cancer, Health, Dentistry, MD

TRINTON FALLS, N.J., Jan. 11, 2023 /PRNewswire-PRWeb/ -- Today, the Advanced Reconstructive Surgery Alliance ("ARSA") welcomes "PRMA" to its national consortium. With the addition of PRMA, ARSA adds a key partner in the southern region of the country and continues to work toward its goal of becoming a nation-wide provider.

Key Points: 
  • TRINTON FALLS, N.J., Jan. 11, 2023 /PRNewswire-PRWeb/ -- Today, the Advanced Reconstructive Surgery Alliance ("ARSA") welcomes " PRMA " to its national consortium.
  • "The surgeons here at PRMA are thrilled to join our colleagues at Advanced Reconstructive Surgery Alliance (ARSA)," stated Minas Chrysopoulo, MD, President of PRMA.
  • The surgeons at PRMA have performed thousands of breast reconstructions, including over 11,000 microsurgical flap procedures, making PRMA one of the leading centers in the world.
  • If interested in learning more about a partnership with ARSA, contact:

Four Lives Transformed Thanks to the Healing Power of Tissue Donation to be Part of the 2023 Donate Life Rose Parade Float, “Lifting Each Other Up”

Retrieved on: 
Thursday, December 22, 2022
Other Consumer, Surgery, Entertainment, Philanthropy, General Entertainment, General Health, Consumer, Health, Foundation, Other Philanthropy, Public sector banks in India, Infection, Health, Mastectomy, Burn, Breast reconstruction, Breast cancer, Acute myeloid leukemia, Tissue, Pasadena Tournament of Roses Association, CTS, Survivor, Walking, Walkers, Transplant, Eye, Rose Parade, American Association of Tissue Banks, Donate Life America, Hypoesthesia, Tree, Woman, Pharmaceutical industry, Dentistry

The 2023 Donate Life Rose Parade float, Lifting Each Other Up, celebrates the power of organ, eye and tissue donation, with donors and recipients working together to support one another.

Key Points: 
  • The 2023 Donate Life Rose Parade float, Lifting Each Other Up, celebrates the power of organ, eye and tissue donation, with donors and recipients working together to support one another.
  • Thanks to tissue donors, millions of people are healed every year and thousands of lives are saved.
  • The 2023 Donate Life Float tissue recipients include the following float riders and walkers:
    Wendy Dougall.
  • Both Wendy and Thomas’ participation in the 2023 Rose Parade are sponsored by Donate Life South Carolina.